PUBLISHER: SkyQuest | PRODUCT CODE: 1554259
PUBLISHER: SkyQuest | PRODUCT CODE: 1554259
Global Ablation Devices Market size was valued at USD 7.92 billion in 2022 and is poised to grow from USD 8.60 billion in 2023 to USD 17.92 billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).
Surgical techniques have undergone significant evolution globally, with substantial advancements in the healthcare sector. These advancements range from adopting cutting-edge screening, diagnostic, and treatment technologies to implementing strategies that minimize post-surgical discomfort. A notable development in this area is the rise of minimally invasive surgery, which has become increasingly favored due to its benefits. As the senior population grows and chronic conditions become more complex, patients are seeking less disruptive treatment options. Minimally invasive surgery offers advantages such as reduced pain, shorter hospital stays, and faster recovery times. A key aspect of minimally invasive procedures is ablation, a technique used to remove biological material from human organs through methods like vaporization, freezing, radiation, or mechanical erosion. In medical practice, ablation is typically employed to excise small tumors or contaminated tissues with minimal invasiveness. Techniques such as chemical ablation and radiofrequency ablation are also utilized to target and eliminate affected biological tissues. The popularity of ablation has surged recently due to its less intrusive nature compared to traditional open surgeries, offering a more comfortable alternative for tumor and tissue removal. With the increasing incidence of chronic diseases, including cancer and cardiovascular issues, the demand for ablation devices is expected to grow.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Ablation Devices Market Segmental Analysis
The global Ablation Devices market is segmented based on product, application, end use, and region. Based on product, the market is segmented into Radiofrequency Devices, Laser/Light Ablators, Ultrasound Devices, Cryoablation Devices, Electric Ablators, Microwave Ablators, Hydrothermal Ablators and Others. Based on application, the market is segmented into Cardiovascular Disease Treatment, Cosmetic/Aesthetic Surgery, Orthopaedic Treatment, Cancer Treatment, Urological Treatment, Gynaecological Treatment, Pain Managment, and Ophthalmological Treatment. Based on end use, the market is segmented into Hospitals, Surgical Centers, And Ablation Centers, Ambulatory Surgical Centers, Medical Spas & Aesthetic Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, and MEA.
Drivers of the Global Ablation Devices Market
A significant driver of market growth is the increasing patient preference for minimally invasive procedures over traditional open surgeries. The popularity of minimally invasive treatments has surged due to their advantages, including shorter hospital stays, quicker recovery, and reduced discomfort compared to conventional methods. Additionally, the growing prevalence of atrial fibrillation among the general population is expected to drive the demand for cardiac ablation procedures. Minimally invasive ablation techniques for atrial fibrillation offer high effectiveness, lower risk, and greater patient convenience. Consequently, the growing adoption of less invasive treatment options and advancements in ablation devices are anticipated to significantly boost the ablation devices market in the coming years.
Restraints in the Global Ablation Devices Market
A notable limitation in the market is the absence of effective conventional first-line treatments for conditions such as liver cancer, uterine fibroids, hemorrhagic stroke, and other hemorrhagic disorders. Traditional therapies, including surgery, chemotherapy, and radiation, remain popular due to widespread public familiarity and acceptance. In particular, there is low adoption of newer treatment options in developing countries, coupled with oncologists' hesitation to move away from established methods. This reluctance to embrace advanced treatments impedes the growth of newer therapeutic approaches in these areas.
Market Trends of the Global Ablation Devices Market
Emerging markets in Asia-Pacific, Africa, and Latin America are anticipated to become increasingly attractive due to advancements in ablation technologies, rising demand for minimally invasive treatments, and growing disposable incomes. Additionally, these regions benefit from a substantial population with undiagnosed conditions, rapid urbanization leading to higher chronic disease rates, increased awareness of prostate cancer, and improved government funding for healthcare. These factors are expected to drive market growth and expand opportunities for ablation technologies in these regions.